NATJUS survey shows 60.7% of technical opinions favor Olaparibe provision for breast cancer

A survey of Judiciary Technical Support Center (NATJUS) opinions reveals a majority support for the provision of Olaparibe in legal health disputes. The data highlights ongoing judicialization of healthcare in Brazil, where technical-scientific assessments are increasingly used to guide court rulings on medication access.